Clinical studies have described the decrease in BDNF levels and cognitive decline in patients with psychiatric disorders such as depression, schizophrenia and bipolar disorder42 and in patients with neuropathological diseases such as epilepsy43, mild cognitive impairment, Alzheimer’s disease44 and Parkinson's disease45. This evidence concerns the gene BDNF and Mental deterioration.